Naples Global Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,595
Closed -$314K 375
2022
Q2
$314K Sell
12,595
-3,900
-24% -$117K 0.04% 311
2022
Q1
$556K Sell
16,495
-25
-0.2% -$822 0.06% 271
2021
Q4
$536K Buy
16,520
+5,280
+47% +$174K 0.06% 272
2021
Q3
$393K Buy
11,240
+1,100
+11% +$43K 0.05% 302
2021
Q2
$422K Buy
10,140
+400
+4% +$16K 0.06% 285
2021
Q1
$359K Buy
9,740
+2,645
+37% +$100K 0.05% 292
2020
Q4
$295K Buy
7,095
+185
+3% +$7.71K 0.05% 301
2020
Q3
$294K Buy
6,910
+50
+0.7% +$2.16K 0.06% 284
2020
Q2
$297K Buy
6,860
+15
+0.2% +$593 0.06% 277
2020
Q1
$225K Buy
6,845
+1,175
+21% +$43.7K 0.06% 282
2019
Q4
$209K Buy
+5,670
New +$201K 0.04% 308

Other funds holding FMS

Naples Global Advisors's FMS Position: Q3 2022 in Review

Naples Global Advisors sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 12,595 shares — an estimated $314K sold.

Naples Global Advisors first reported a position in FMS in Q4 2019 and held it in 11 quarters. The position peaked at $556K in Q1 2022. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

  • Naples Global Advisors reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
  • Naples Global Advisors sold 12,595 Fresenius Medical Care shares in Q3 2022, an estimated $314K.
  • Naples Global Advisors first reported a position in Fresenius Medical Care in Q4 2019 and held it in 11 quarters.
  • Naples Global Advisors's Fresenius Medical Care position peaked at $556K in Q1 2022.
  • 141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on Naples Global Advisors's 13F filing for Q3 2022, filed 20 Oct 2022.